Nature S Sunshine Products Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Nature S Sunshine Products Inc 's ROA in the second quarter of 2026?
Nature s Sunshine Products inc achieved a return on average assets (ROA) of 7.14 % in its second quarter of 2026, this is above NATR's average return on assets of 5.12%.
Nature S Sunshine Products Inc assets over the 12 months ending in its second quarter of 2026 are valued at $262 million

ROA decreased relative to the period ending Mar 31 2026, due to the decline in net income.

However, within the Healthcare sector 125 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 776, from total ROA ranking in the first quarter of 2026 at 908.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	1.94 %	3.46 %	16.5 %	13.88 %	14.88 %
Y / Y Net Income Change	-35.89 %	4.79 %	-	19.13 %	270.9 %
Net Income (TTM) in million	19	21	20	15	14
Return On Assets (TTM)	7.14 %	7.94 %	7.92 %	6.1 %	5.94 %
NATR's Total Ranking	# 776	# 908	# 1025	# 1050	# 1326
Total Assets (TTM) in million	260	261	261	265	255
Seq. Total Assets Change	-0.63 %	0.12 %	-1.38 %	3.9 %	0.86 %
Seq. Net Income Change	-30.87 %	13.41 %	-18.46 %	0.29 %	13 %

NATR's 5 Years Annual ROA >> Back to NATR Management Effectiveness >> Compare NATR ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 48
Sector	# 126
Overall	# 868

Return On Assets Statistics
High	Average	Low
15.64 %	5.12 %	-8.28 %
(Sep 30 2012)		(Sep 30 2018)

Financial Statements
Nature S Sunshine Products Inc 's Assets	$ 260 million	NATR's Balance sheet
Nature S Sunshine Products Inc 's Income	$ 4 million	Quarterly NATR's Income Statement
NATR's Income by Division		See NATR's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	16.5 %	-4.54 %	4.98 %	-9.27 %	2.11 %
Total Assets in million	261	224	235	224	247
Y / Y Net Income Change	159.14 %	-51.92 %	2884.73 %	-98.18 %	31.58 %
Net Income in million	20	8	16	1	30
Annual Return On Assets	7.83 %	3.52 %	6.99 %	0.25 %	12.25 %

NATR's 5 Years Annual ROA >> Back to NATR Management Effectiveness >> Compare NATR ROA to its Competitors

Comment on NATR's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 7.83 % compared to prior year, due to annual net income growth of 159.14 % to $20.45 million, while value of Nature S Sunshine Products Inc 's overall assets grew just by 16.5 % to $261.15 million, compared to $261.15 a year before.

More Return On Assets Ratios
NATR's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NATR's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NATR's Competitors
Subscribers only: Roa for Nature S Sunshine Products Inc 's Suppliers
Subscribers only: Return On Assets for NATR's Customers

You may also want to know
NATR's Roi	NATR's Inventory Turnover Ratio	NATR's Growth Rates	NATR's Dividend Comparisons
	NATR's Profitability Ratios	NATR's Asset Turnover Ratio	NATR's Dividend Growth
NATR's Roe	NATR's Valuation Ratios	NATR's Financial Strength Ratios	NATR's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Electromed Inc	19.39 %
United Therapeutics Corporation	17.98 %
Resmed Inc	17.80 %
Krystal Biotech Inc	17.65 %
Chemed Corporation	17.52 %
Zoetis Inc	17.19 %
Vertex Pharmaceuticals Inc	16.88 %
Halozyme Therapeutics Inc	16.55 %
Alnylam Pharmaceuticals Inc	15.76 %
Intuitive Surgical Inc	15.63 %
Healthcare Services Group Inc	15.21 %
Inspire Medical Systems inc	15.21 %
Dexcom Inc	14.87 %
Neurocrine Biosciences Inc	14.73 %
Entera Bio Ltd	14.60 %
Standard Biotools Inc	14.31 %
Arcutis Biotherapeutics Inc	14.23 %
Harmony Biosciences Holdings inc	14.15 %
Biolife Solutions Inc	14.09 %
Aveanna Healthcare Holdings Inc	13.82 %
West Pharmaceutical Services Inc	13.64 %
Medinotec Inc	13.38 %
Puma Biotechnology Inc	13.28 %
Sbc Medical Group Holdings Incorporated	13.26 %
Alpha Pro Tech Ltd	13.17 %
Illumina Inc	12.68 %
Spero Therapeutics Inc	12.57 %
Transmedics Group Inc	12.50 %
Eton Pharmaceuticals Inc	12.37 %
Nephros Inc	12.30 %

Date modified: 2026-09-05T15:20:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.